Assetmark, Inc Vanda Pharmaceuticals Inc. Transaction History

Assetmark, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$3.38 - $4.58 $87 - $119	-26 Reduced 45.61%	31 $0
Q4 2022 Feb 10, 2023	SELL	$6.87 - $10.96 $192 - $306	-28 Reduced 32.94%	57 $0
Q3 2022 Nov 01, 2022	SELL	$9.44 - $11.76 $695,558 - $866,500	-73,682 Reduced 99.88%	85 $1,000
Q2 2022 Aug 03, 2022	BUY	$9.31 - $11.84 $143,374 - $182,336	15,400 Added 26.38%	73,767 $804,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $155,629 - $237,608	14,357 Added 32.62%	58,367 $660,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $43,241 - $58,261	-2,756 Reduced 5.89%	44,010 $691,000
Q3 2021 Nov 12, 2021	BUY	$15.35 - $21.27 $60,617 - $83,995	3,949 Added 9.22%	46,766 $802,000
Q2 2021 Aug 16, 2021	BUY	$15.71 - $21.51 $84,708 - $115,981	5,392 Added 14.41%	42,817 $921,000
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $117,049 - $176,882	8,722 Added 30.39%	37,425 $562,000
Q4 2020 Feb 10, 2021	BUY	$9.77 - $13.81 $45,371 - $64,133	4,644 Added 19.3%	28,703 $377,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $109,528 - $141,259	11,752 Added 95.49%	24,059 $232,000
Q2 2020 Aug 11, 2020	BUY	$9.66 - $12.02 $118,885 - $147,930	12,307 New	12,307 $141,000

161

45.3M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $283M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.